China's 2026 Ad Enforcement: Misleading Claims and Fake Citations

If your brand leans on phrases like "No.1," "best-in-class," or "clinically proven" in ad copy, China's 2026 enforcement cycle has a message for you: those claims now carry real legal risk unless you can prove them — and prove the source.

At an e-commerce governance conference on August 30, regulators put a name to the two priorities driving ad enforcement this year: misleading claims and fake citations. They are not new problems, but the rules that finally make them actionable are. For overseas brands running campaigns on Baidu, the practical consequence is simple: the copy that works in Western markets is often the exact copy that violates Chinese ad law.

🎯 Two Enforcement Priorities for 2026

The August 30 conference framed 2026 around two problems. The first is "big claims, small disclaimers" — ads that scream a benefit in large type while burying the conditions, limits, or exceptions in fine print. The second is "carrot-hole citations" — fake third-party data designed to manufacture a "No.1" result.

Both trace back to two documents that gave regulators the teeth they needed. The first is the Citation Content Enforcement Guide, issued by the State Administration for Market Regulation (SAMR) on June 3, 2026 — the first rule dedicated entirely to how advertisers may (and may not) cite data. The second is the Notice on Strengthening Supervision of Prompt Language in Advertising, issued March 6, 2026, which launched a six-month nationwide cleanup.

For an overseas advertiser, these documents matter more than most policy announcements, because they attach specific legal consequences to habits that Western marketing teams consider normal.

🥕 "Carrot-Hole Citations": The Fake "No.1" Tactic

Chinese regulators have a sharp name for a very common trick: "carrot-hole citation" (萝卜坑式引证). The idea is to draw the target around the arrow after you have fired it. If you define a niche narrowly enough — "No.1 in adult anti-cavity fresh-breath toothpaste" — almost any product can claim to be the champion of some category.

A widely cited example is four toothpaste brands, all of which claimed "No.1 in sales" at the same time — each in a slightly different, self-invented subcategory. The data was real in the sense that a survey existed; what was fake was the premise, because the category was engineered to guarantee the result.

The new rules target exactly this. Advertisers can no longer shift blame to a third-party research firm by saying "the agency gave us the data." Under the Citation Content Enforcement Guide, the advertiser bears the burden of proof for every citation. If the claim is challenged, you must be able to produce the underlying report, methodology, and source — not point at a vendor.

🔍 "Big Claims, Small Disclaimers": Misleading Fine Print

The second priority is the layout trick that has become ubiquitous in performance marketing: the headline promise in large, bright type, and the qualification — "first 50 customers only," "minimum spend applies," "results vary" — in a size and color designed to be ignored.

The March notice makes this explicit. Ads must not use font size, color, or position to hide information that would change a consumer's decision. A performance claim that turns out to be "just a corporate vision" or "for illustration only" — disclosed only in fine print — can now be classified as false advertising, not just poor taste.

This is a structural risk for overseas brands, because Western ad formats almost always carry legal disclaimers in small type at the bottom. What is standard practice in the U.S. or Europe is precisely the pattern Chinese regulators are now penalizing.

📋 The New Citation Guide: What Advertisers Must Prove

The Citation Content Enforcement Guide is the document to read carefully. It defines citation content as any data, statistics, survey results, excerpts, or quotes attributed to a third party and used to promote your product. It then sets hard requirements:

• Real and verifiable. Citations must be true, accurate, and legal. Fabricated, forged, or unverifiable content is prohibited.
• Qualified sources. Data from experiments, measurements, or tests must come from institutions with proper legal qualifications and compliant methods.
• Scientific sampling. Statistics and surveys must use scientific methods, with samples that are representative and reasonable in scope.
• Accurate attribution. Excerpts and quotes must match the original meaning, and the source must be real and findable.
• Full disclosure. Every citation must state its source — the institution, journal name and issue, or web path.

For overseas brands, the highest-risk item is the last one. Western ad teams routinely cite "industry data" or "market research" without naming the source. Under the new guide, an unnamed citation is no longer a minor gap; it is a compliance failure waiting to be flagged.

🚫 Two More Red Lines: Superlatives and AI Ads

The 2026 cycle also sharpens two adjacent rules that trip up foreign advertisers constantly.

The first is absolute terms. China's Advertising Law has long banned words like "national-level," "best," "top," and "No.1" — and the 2026 cleanup extends this to disguised variants: homophones, abbreviations, pinyin substitutions, and symbol swaps. "No.1" written as "NO.1" or "#1" is still "No.1." For brands whose home-market playbook is built on superlatives, this is the single most common violation.

The second is AI-generated ads. The March notice explicitly covers AI content: if an ad uses AI to generate someone's likeness without consent, or uses a fictional AI character to recommend or endorse a product without clear AI labeling, it can be treated as false advertising. Given how aggressively overseas brands are now adopting AI for creative, this is a live risk, not a hypothetical one.

✅ What Overseas Brands Should Do Now

The enforcement trend is clear, and it will not reverse. But the fix is not to abandon strong claims — it is to make them defensible. Three practical steps:

1. Audit every superlative. Go through your Baidu landing pages and ad copy and remove or rewrite every "No.1," "best," and "top" claim that cannot be backed by a qualified, named source.
2. Keep the evidence file. For any data you do cite, store the full report, methodology, and source. The burden of proof is now yours, and regulators can ask for it at any time.
3. Fix the fine print. Move material conditions out of fine print and into the same visual weight as the claim. A disclaimer that is easy to ignore is no longer a defense.

For overseas teams, the hard part is rarely intent — it is knowing which rules apply to a market they do not operate in every day. That is the gap we close: we review your ad copy and landing pages against China's current enforcement standards before you spend, flag every superlative and unnamed citation, and keep you on the right side of a regime that is no longer issuing warnings.